1,021
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Approaches to the Discovery of Pharmacogenomic Markers in Oncology: 2000–2010–2020

&
Pages 471-474 | Published online: 29 Mar 2010

Figures & data

Figure 1. Timeline of pharmacogenetic prognostic tools and drug development from 2000 to 2020.

(A) Time of approval of various cancer therapies based on US FDA approval time. (B) Timeline to show the establishment of pharmacogenetic prognostic tools.

DMET: Drug-metabolizing enzymes and transporters; HDAC: Histone deacetylase.

Figure 1. Timeline of pharmacogenetic prognostic tools and drug development from 2000 to 2020. (A) Time of approval of various cancer therapies based on US FDA approval time. (B) Timeline to show the establishment of pharmacogenetic prognostic tools.DMET: Drug-metabolizing enzymes and transporters; HDAC: Histone deacetylase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.